Quarterly Activity Chart
Adds vs. Reduces by Quarter
PaperPanda Equity Terminal
ABCL —
ABCELLERA BIOLOGICS INC
CUSIP: 00288U106 · Held by 3 superinvestors · Combined value: $16,153,839
Latest News
Loading financials…
| # | Investor | % of Portfolio | Value ($) | Shares | Recent Activity | Share Change |
|---|---|---|---|---|---|---|
| 1 | Jim Simons | 0.0% | $8,171,163 | 2,389,229 | REDUCE | -971,500 |
| 2 | Ken Griffin | 0.0% | $7,632,099 | 2,231,608 | ADD | +749,293 |
| 3 | Polen Capital | 0.0% | $350,577 | 102,508 | REDUCE | -166,740 |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Ken Griffin | ADD | +749,293 | +50.5% |
| Jim Simons | REDUCE | -971,500 | -28.9% |
| Polen Capital | REDUCE | -166,740 | -61.9% |
| Investor | Activity | Share Change | % Change |
|---|---|---|---|
| Polen Capital | NEW BUY | +269,248 | New |
| Jim Simons | ADD | +53,300 | +1.6% |
| Ken Griffin | REDUCE | -1,688,245 | -53.2% |
Who Owns ABCL? Superinvestor Holdings
ABCELLERA BIOLOGICS INC is held by 3 tracked superinvestors, with a combined position value of $16 million . The largest positions are held by Jim Simons (0.0% of portfolio), Ken Griffin (0.0% of portfolio), Polen Capital (0.0% of portfolio).
In the most recent quarter, 1 superinvestor added or initiated positions while 2 reduced or exited.